Organogenesis Holdings (ORGO) Cash from Operations Growth (1y) (2017 - 2026)
Organogenesis Holdings (ORGO) Cash from Operations Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | 0.46% |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 425.00% |
| 10 | Organogenesis Holdings | 329.08 Mn | 236.98 Mn | 11.46 Mn | 205.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 205.98% |
| Dec 31, 2025 | 260.43% |
| Sep 30, 2025 | -64.59% |
| Jun 30, 2025 | -793.82% |
| Mar 31, 2025 | -96.17% |
| Dec 31, 2024 | 3.04% |
| Sep 30, 2024 | -48.04% |
| Jun 30, 2024 | -45.20% |
| Mar 31, 2024 | -100.16% |
| Dec 31, 2023 | 36.08% |
| Sep 30, 2023 | 206.88% |
| Jun 30, 2023 | -15.19% |
| Mar 31, 2023 | -459.82% |
| Dec 31, 2022 | -56.54% |
| Sep 30, 2022 | -80.42% |
| Jun 30, 2022 | -41.68% |
| Mar 31, 2022 | 208.54% |
| Dec 31, 2021 | -22.69% |
| Sep 30, 2021 | 214.02% |
| Jun 30, 2021 | 287.25% |